Cassidy Bio

About

Headcount over time

Offices

Q&A

What is Cassidy Bio's primary focus?

Cassidy Bio is an AI-first biotechnology company focused on building a programmable platform for gene editing, aiming to drive genome editing therapeutics forward.

When was Cassidy Bio founded?

Cassidy Bio was founded in March 2024.

Where is Cassidy Bio headquartered?

Cassidy Bio is headquartered in Tel Aviv-Yafo, Israel.

How much funding has Cassidy Bio raised to date?

Cassidy Bio has raised a total of $8,000,000 USD.

When was Cassidy Bio's last funding round and who were the investors?

Cassidy Bio's last funding round was in August 2024, with participation from AION Labs and 10D.

What is Cassidy Bio's current employee count?

Cassidy Bio has 11-50 employees.

What technologies does Cassidy Bio utilize?

Cassidy Bio utilizes Biologicals, Genes, Artificial Intelligence, and Machine Learning technologies.

What industries does Cassidy Bio target with its solutions?

Cassidy Bio targets the Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, and Biotechnology industries.

Team · 8

Rom Kshuk

Founder · Co-founder & CEO

Ayal Hendel

Founder · Co-founder & CSO

Yaniv Shmueli

Founder · Co-founder & CTO

Vic Myer

Scientific Advisory Board (former CTO of Editas Medicine)

Saar Gill

Scientific Advisory Board (University of Pennsylvania)

Doron Lipson

Scientific Advisory Board (former CSO of Ultima Genomics)

Daniel O'Connell

Scientific Advisory Board (formerly Intellia Therapeutics)

Yael Yoffe Mizrahi

NK cell therapy expert

Sectors & technology

Tags